Kit for early diagnosis of nasal pharyngeal cancer (NPC)
An early diagnosis and reagent technology, applied in the field of kits for early diagnosis of NPC, can solve problems such as inability to diagnose nasopharyngeal carcinoma patients, achieve good diagnostic value, simple operation, and reduce missed diagnosis.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0031] Epstein-Barr virus glycoproteins gH (gp85) and gL exist in the form of heterodimers, the content of which is second only to gp350 in glycoproteins. , host range, tissue tropism, and membrane fusion are closely related. The glycoprotein gH of other types of herpesviruses has been reported many times before to induce immune responses. For example, the varicella-zoster virus glycoprotein complex gH / gL contains a domain structure that can react with the gamma chain of human immunoglobulin IgG; the baculovirus system expresses the recombinant fibrous papilloma-associated herpes virus glycoprotein gH using ELISA. In the diagnosis of fibrous papillomas in sea turtles. However, because the pathogenic mechanism of NPC is not very clear, there is no experimental data showing that the Epstein-Barr virus glycoprotein complex gH / gL is related to the progression of NPC.
[0032] A method for early diagnosis or screening of nasopharyngeal carcinoma, comprising the steps of:
[0033...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com